BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1556880)

  • 1. Trends in the utilization of mammography in Washington state and British Columbia: relation to stage of diagnosis and mortality.
    Katz SJ; Larson EB; LoGerfo JP
    Med Care; 1992 Apr; 30(4):320-8. PubMed ID: 1556880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.
    Coldman AJ; Phillips N; Olivotto IA; Gordon P; Warren L; Kan L
    J Med Screen; 2008; 15(4):182-7. PubMed ID: 19106258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer mortality after screening mammography in British Columbia women.
    Coldman A; Phillips N; Warren L; Kan L
    Int J Cancer; 2007 Mar; 120(5):1076-80. PubMed ID: 17149701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97.
    Olivotto IA; Kan L; d'Yachkova Y; Burhenne LJ; Hayes M; Hislop TG; Worth AJ; Basco VE; King S
    J Med Screen; 2000; 7(3):152-9. PubMed ID: 11126165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography use, breast cancer stage at diagnosis, and survival among older women.
    McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
    J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
    Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
    AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delay from symptom to diagnosis and treatment of breast cancer in Washington State and British Columbia.
    Katz SJ; Hislop TG; Thomas DB; Larson EB
    Med Care; 1993 Mar; 31(3):264-8. PubMed ID: 8450682
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the increase in breast cancer incidence in relation to mammography use.
    White E; Lee CY; Kristal AR
    J Natl Cancer Inst; 1990 Oct; 82(19):1546-52. PubMed ID: 2402016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
    Weisstock CR; Rajapakshe R; Bitgood C; McAvoy S; Gordon PB; Coldman AJ; Parker BA; Wilson C
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1084-92. PubMed ID: 23963801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
    Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
    Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening mammography in British Columbia: 1988-1993.
    Clay MG; Hislop TG; Kan L; Olivotto IA; Burhenne LJ
    Am J Surg; 1994 May; 167(5):490-2. PubMed ID: 8185033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends in breast cancer incidence, mortality, and mammography.
    Newcomb PA; Lantz PM
    Breast Cancer Res Treat; 1993 Nov; 28(2):97-106. PubMed ID: 8173073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes.
    Onega T; Goldman LE; Walker RL; Miglioretti DL; Buist DS; Taplin S; Geller BM; Hill DA; Smith-Bindman R
    J Med Screen; 2016 Mar; 23(1):31-7. PubMed ID: 26265482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer statistics, 2011.
    DeSantis C; Siegel R; Bandi P; Jemal A
    CA Cancer J Clin; 2011; 61(6):409-18. PubMed ID: 21969133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program.
    Kan L; Olivotto IA; Warren Burhenne LJ; Sickles EA; Coldman AJ
    Radiology; 2000 May; 215(2):563-7. PubMed ID: 10796940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy.
    Fong A; Shafiq J; Saunders C; Thompson A; Tyldesley S; Olivotto IA; Barton MB; Dewar JA; Jacob S; Ng W; Speers C; Delaney GP
    Breast; 2012 Aug; 21(4):562-9. PubMed ID: 22297168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy.
    Fong A; Shafiq J; Saunders C; Thompson AM; Tyldesley S; Olivotto IA; Barton MB; Dewar JA; Jacob S; Ng W; Speers C; Delaney GP
    Breast; 2012 Aug; 21(4):570-7. PubMed ID: 22425535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening mammography program of British Columbia.
    Clay MG
    Am J Surg; 1990 May; 159(5):470-2. PubMed ID: 2334009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER Registry.
    Richman I; Asch SM; Bendavid E; Bhattacharya J; Owens DK
    J Gen Intern Med; 2017 Jun; 32(6):603-609. PubMed ID: 27844260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population studies of the effectiveness of mammographic screening.
    Coldman A; Phillips N
    Prev Med; 2011 Sep; 53(3):115-7. PubMed ID: 21798279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.